Form 483

Philips North America LLC Form 483, 2021-08-20

FDA issued a Form 483 to Philips North America LLC on 2021-08-20 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Philips North America LLC · Bothell, United States · Issued August 20, 2021

Overview

  • 6 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Aug 2021
21 CFR 803.56

Submission of Supplement to Individual Report Within One Month

Cited by Stephen R Souza, Christopher S Genther

20 Aug 2021
21 CFR 803.56

Submission of Supplement to Individual Report Within One Month

Cited by Stephen R Souza, Christopher S Genther

20 Aug 2021
21 CFR 820.70(g)(2)

Periodic equipment inspection lack of or inadequate procedu

Cited by Stephen R Souza, Christopher S Genther

20 Aug 2021
21 CFR 820.70(g)(2)

Periodic equipment inspection lack of or inadequate procedu

Cited by Stephen R Souza, Christopher S Genther

20 Aug 2021
21 CFR 820.90(b)(1)

Procedures for product review,disposition lack of/inadequate

Cited by Stephen R Souza, Christopher S Genther

Inspected site

PNPhilips North America LLCBothell, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.56Cited across public-safe Form 483 observations2x
21 CFR 820.70(g)(2)Cited across public-safe Form 483 observations2x
21 CFR 820.90(b)(1)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere